#152631

Anti-NCAM [UJ13A]

Cat. #152631

Anti-NCAM [UJ13A]

Cat. #: 152631

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Neural Cell Adhesion Molecule (NCAM; CD56)

Class: Monoclonal

Application: IF ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: John Kemshead

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-NCAM [UJ13A]
  • Alternate name: Neural Cell Adhesion Molecule; NCAM; CD56 Antigen; MSK39
  • Research fields: Cell biology;Cell signaling and signal transduction;Neurobiology;Stem cell biology
  • Clone: UJ13A
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 180 kDa, 160 kDa, 120 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: IF ; WB
  • Description: NCAM, also known as CD56, is a homophillic binding glycoprotein present on a variety of neural cells including neurons, glia, skeletal muscle and natural killer cells. NCAM has been implicated as having a role in cell-cell adhesion, neurite outgrowth, synatptic plasticity, learning and memory and in the development of the nervous system.
  • Immunogen: 16 week human foetal brain
  • Isotype: IgG1

Target Details

  • Target: Neural Cell Adhesion Molecule (NCAM; CD56)
  • Molecular weight: 180 kDa, 160 kDa, 120 kDa
  • Target background: NCAM, also known as CD56, is a homophillic binding glycoprotein present on a variety of neural cells including neurons, glia, skeletal muscle and natural killer cells. NCAM has been implicated as having a role in cell-cell adhesion, neurite outgrowth, synatptic plasticity, learning and memory and in the development of the nervous system.

Applications

  • Application: IF ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Patel et al. 1989. Int J Cancer. 44(6):1062-8. PMID: 2558078.
  • Patel et al. 1989. Br J Cancer. 60(6):861-6. PMID: 2481486.
  • Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.
  • Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM).
  • Moss et al. 1988. Lung Cancer. 4, 76-78.
  • Allan et al. 1983. Int J Cancer. 31(5):591-8. PMID: 6852977.
  • Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.